Bluebird Bio reported $-190797000 in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agios Pharmaceuticals AGIO:US $ -102.62M 13.68M
Applied Genetic Technologies AGTC:US $ -13.1M 4.79M
Arrowhead Research ARWR:US $ 44.15M 104.9M
Mirati Therapeutics MRTX:US $ -183.59M 12.92M
Nektar Therapeutics NKTR:US $ -109.47M 0.5M
Novartis NOVN:VX SF 4214M 623M
Sangamo Biosciences SGMO:US $ -42.43M 5.29M